Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ANTHOS PHACTS VERSION MICROPLATE READER

K-Number: K962113 · 1996-11-05

ApplicantColumbia Bioscience, Inc.
Decision Date1996-11-05
Product CodeJJQ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

ANTHOS PHACTS VERSION MICROPLATE READER is the device name listed in this FDA 510(k) record. The listed applicant is Columbia Bioscience, Inc.. It received FDA 510(k) clearance on 1996-11-05 under 510(k) number K962113. The device is classified under product code JJQ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ANTHOS PHACTS VERSION MICROPLATE READER?

ANTHOS PHACTS VERSION MICROPLATE READER is a medical device that received FDA 510(k) clearance on 1996-11-05. The listed applicant is Columbia Bioscience, Inc.. The 510(k) number is K962113.

When did ANTHOS PHACTS VERSION MICROPLATE READER receive FDA 510(k) clearance?

ANTHOS PHACTS VERSION MICROPLATE READER received FDA 510(k) clearance on 1996-11-05, under 510(k) number K962113.

Who is the listed applicant for ANTHOS PHACTS VERSION MICROPLATE READER?

The FDA 510(k) record lists Columbia Bioscience, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ANTHOS PHACTS VERSION MICROPLATE READER?

The FDA product code for ANTHOS PHACTS VERSION MICROPLATE READER is JJQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Columbia Bioscience, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K991274MUMPS IGG ELISA TEST SYSTEMK990462IS H. PYLORI IGG ELISA TEST SYSTEMK984228IS ANTI-TPO IGG ELISA TEST SYSTEMK983606IS BORRELIA BURGDORFERI IGM TEST SYSTEMK983605IS BORRELIA BURGDORFERI IGG/IGM ELISA TEST SYSTEMK983553ANTI-TG IGG ELISA TEST SYSTEM

View all 13 devices →

Related Devices (Code: JJQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K013371UBIT-IR300 INFRARED SPECTROMETRY SYSTEMOtsuka Pharmaceutical Co., Ltd.K980120DIGENE DML 2000 MICROPLATE LUMINOMETERDigene Corp.K973938ALPHA 4 LS AUTOMATED MICROTITERPLATE PROCESSOR AND READERSfri, Inc.K974762STAT TRACKSAwareness Technology, Inc.K961183CBI 7520 READERColumbia Bioscience, Inc.K962166ORIGEN ANALYZERIgen, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑